Growth Metrics

Resmed (RMD) Operating Leases (2019 - 2025)

Resmed's Operating Leases history spans 7 years, with the latest figure at $154.1 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 10.76% year-over-year to $154.1 million; the TTM value through Dec 2025 reached $154.1 million, up 10.76%, while the annual FY2025 figure was $153.0 million, 8.18% up from the prior year.
  • Operating Leases reached $154.1 million in Q4 2025 per RMD's latest filing, up from $147.8 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $154.1 million in Q4 2025 to a low of $112.4 million in Q3 2023.
  • Average Operating Leases over 5 years is $130.1 million, with a median of $130.1 million recorded in 2021.
  • Peak YoY movement for Operating Leases: decreased 12.43% in 2022, then rose 28.49% in 2024.
  • A 5-year view of Operating Leases shows it stood at $133.0 million in 2021, then dropped by 12.43% to $116.4 million in 2022, then grew by 20.79% to $140.6 million in 2023, then dropped by 1.06% to $139.2 million in 2024, then increased by 10.76% to $154.1 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Operating Leases are $154.1 million (Q4 2025), $147.8 million (Q3 2025), and $153.0 million (Q2 2025).